Resources
Find the publications relevant to your drug development programs.
Drug Type
- Small Molecule/Tyrosine Kinase Inhibitors
- Adoptive Cell Therapies
- Antibody Dependent Cellular Cytotoxicity
- Checkpoint Inhibitors
- Cell Therapies
- Antibody Drug Conjugates
- Other
Cancer Type
- Lung
- Kidney
- Brain
- NSCLC
- HNSCC
- Renal
- Colorectal
- Bladder
- Other
Need Help?
Contact Us for support
May 10, 2021
Inhibition of IDO activity by epacadostat (INCB024360) activates tumor infiltrating lymphocytes in a patient-derived 3D ex vivo system of lung cancer and alleviates stromal immunosuppression
May 10, 2021
Impact of combined blockade of PD1 and activation of CD137 on tumor infiltration and tumor cell killing efficacy of TILs in an ex vivo autologous 3D tumoroid model of NSCLC patient samples
Oct 21, 2020
An ex vivo tumoroid model of fresh patient tumors (3D-ACTSM) to assess efficacy of cellular therapy in immuno-oncology
Oct 21, 2020
Determining the efficacy of ADCC by the 3D-EXSM ex vivo platform utilizing tumoroids of fresh patient tumor samples with intact tumor microenvironment
Oct 21, 2020
Evaluating the effectiveness of targeting ADC therapy in a patient-derived ex vivo tumoroid model, 3D-EX, for quantitative tumor cell killing
